IBDEI1NG ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26341,1,4,0)
 ;;=4^I50.41
 ;;^UTILITY(U,$J,358.3,26341,2)
 ;;=^5007248
 ;;^UTILITY(U,$J,358.3,26342,0)
 ;;=I50.42^^107^1238^7
 ;;^UTILITY(U,$J,358.3,26342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26342,1,3,0)
 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,26342,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,26342,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,26343,0)
 ;;=I50.43^^107^1238^6
 ;;^UTILITY(U,$J,358.3,26343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26343,1,3,0)
 ;;=3^Heart Failure,Systolic & Diastolic,Acute on Chronic
 ;;^UTILITY(U,$J,358.3,26343,1,4,0)
 ;;=4^I50.43
 ;;^UTILITY(U,$J,358.3,26343,2)
 ;;=^5007250
 ;;^UTILITY(U,$J,358.3,26344,0)
 ;;=I50.9^^107^1238^13
 ;;^UTILITY(U,$J,358.3,26344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26344,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,26344,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,26344,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,26345,0)
 ;;=I09.81^^107^1238^15
 ;;^UTILITY(U,$J,358.3,26345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26345,1,3,0)
 ;;=3^Rheumatic Heart Failure
 ;;^UTILITY(U,$J,358.3,26345,1,4,0)
 ;;=4^I09.81
 ;;^UTILITY(U,$J,358.3,26345,2)
 ;;=^5007059
 ;;^UTILITY(U,$J,358.3,26346,0)
 ;;=E86.0^^107^1239^1
 ;;^UTILITY(U,$J,358.3,26346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26346,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,26346,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,26346,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,26347,0)
 ;;=E86.1^^107^1239^4
 ;;^UTILITY(U,$J,358.3,26347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26347,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,26347,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,26347,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,26348,0)
 ;;=E86.9^^107^1239^5
 ;;^UTILITY(U,$J,358.3,26348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26348,1,3,0)
 ;;=3^Volume Depletion,Unspec
 ;;^UTILITY(U,$J,358.3,26348,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,26348,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,26349,0)
 ;;=E87.0^^107^1239^2
 ;;^UTILITY(U,$J,358.3,26349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26349,1,3,0)
 ;;=3^Hyperosmolality & Hpernatremia
 ;;^UTILITY(U,$J,358.3,26349,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,26349,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,26350,0)
 ;;=E87.1^^107^1239^3
 ;;^UTILITY(U,$J,358.3,26350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26350,1,3,0)
 ;;=3^Hypo-osmolality & Hyponatremia
 ;;^UTILITY(U,$J,358.3,26350,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,26350,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,26351,0)
 ;;=E10.10^^107^1240^18
 ;;^UTILITY(U,$J,358.3,26351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26351,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/o Coma
 ;;^UTILITY(U,$J,358.3,26351,1,4,0)
 ;;=4^E10.10
 ;;^UTILITY(U,$J,358.3,26351,2)
 ;;=^5002587
 ;;^UTILITY(U,$J,358.3,26352,0)
 ;;=E10.11^^107^1240^17
 ;;^UTILITY(U,$J,358.3,26352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26352,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/ Coma
 ;;^UTILITY(U,$J,358.3,26352,1,4,0)
 ;;=4^E10.11
 ;;^UTILITY(U,$J,358.3,26352,2)
 ;;=^5002588
 ;;^UTILITY(U,$J,358.3,26353,0)
 ;;=E10.21^^107^1240^8
 ;;^UTILITY(U,$J,358.3,26353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26353,1,3,0)
 ;;=3^DM Type 1 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,26353,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,26353,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,26354,0)
 ;;=E10.22^^107^1240^3
